Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unfractionated heparin pretreatment in STEMI
NCT05247424Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Mar 2022
- Primary completion
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of heparin in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Thrombolysis in Myocardial Infarction flow at Day 0. Started Mar 2022; status: completed.
02
Drugs
heparin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT05247424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05247424.